Clinical Trial Update: Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use [Phase 1]

View source ↗

Summary

A Phase 1 trial reports on the bioavailability of a new nasal naloxone formulation intended for prehospital use in opioid overdose scenarios.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• Naloxone nasal formulation (Naloxone)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Drug Overdose | Phase 1 | Status: COMPLETED